Gain Therapeutics Inc. (GANX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Greenlight Capital

David Einhorn

566,130 $2,134,310 0.09%
2.
Millennium Management

Israel Englander

44,416 $167,448 +248% 0%
3.
Springbok Capital

Gavin Saitowitz And Cisco J. Del Valle

35,820 $135,041 -39% 0%
4. 5,600 $21,112 +274% 0%
5. 4,223 $15,921 -94% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.21 12,000 Director 289,629 2024-07-01 Filing
$1.23 5,000 Director 277,629 2024-07-01 Filing
$3.86 30,000 Director 30,000 2024-03-28 Filing
$2.58 2,482 217,729 2022-05-25 Filing
$2.83 9,256 215,247 2022-05-20 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.46 206 Officer, Director 5,286 2023-12-21 Filing
$2.50 1,820 Officer, Director 4,855 2023-12-07 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 200,248 $654,000 0%
2. 151,476 $494,649 0%
3. 90,000 $293,850 0.23%
4. 88,385 $288,577 0%
5. 46,100 $150,517 0%
News See All